Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT

The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer

(2020) Sian M. Noble et al.   BRITISH JOURNAL OF CANCER

Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems

(2018) Rosa U. Greasley et al.   BMC CANCER

Genomic Markers in Prostate Cancer Decision Making

(2018) Vito Cucchiara et al.   EUROPEAN UROLOGY

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality

(2018) Richard M. Martin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial

(2018) Jenny L. Donovan et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Training health professionals to recruit into challenging randomized controlled trials improved confidence: the development of the QuinteT randomized controlled trial recruitment training intervention

(2018) Nicola Mills et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model: An Individual Patient Data Meta-Analysis

(2018) Andrew Vickers et al.   JOURNAL OF UROLOGY

New biomarkers for diagnosis and prognosis of localized prostate cancer

(2018) Dimitry A. Chistiakov et al.   SEMINARS IN CANCER BIOLOGY

Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework

(2018) Caroline Wilson et al.   Trials

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

(2018) Tyler M Seibert et al.   BMJ-British Medical Journal

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

(2018) Tyler M Seibert et al.   BMJ-British Medical Journal

Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study

(2018) Louise Clare Brown et al.   HEALTH TECHNOLOGY ASSESSMENT

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT

(2018) Freddie C Hamdy et al.   HEALTH TECHNOLOGY ASSESSMENT

Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial

(2017) Thomas J. Johnston et al.   EUROPEAN UROLOGY

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2017) Nicolas Mottet et al.   EUROPEAN UROLOGY

Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer

(2017) Freddie C. Hamdy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer

(2017) Kirsten Bibbins-Domingo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years

(2017) Daniel A. Barocas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer

(2017) Ronald C. Chen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above

(2017) Andrew Vickers et al.   JOURNAL OF UROLOGY

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

(2017) Abdel-Rahmène Azzouzi et al.   LANCET ONCOLOGY

Prostate Cancer Screening — A Perspective on the Current State of the Evidence

(2017) Paul F. Pinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC)

(2017) Julia Wade et al.   Trials

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

(2017) Amit Sud et al.   Nature Communications

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study

(2017) Vasiliki I Dimitrakopoulou et al.   BMJ-British Medical Journal

Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study

(2017) Vasiliki I Dimitrakopoulou et al.   BMJ-British Medical Journal

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life

(2016) Athene Lane et al.   BJU INTERNATIONAL

Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohorts

(2016) Andrew J. Simpkin et al.   BJU INTERNATIONAL

Symptomatic and quality-of-life outcomes after treatment for clinically localised prostate cancer: a systematic review

(2016) Penny F. Whiting et al.   BJU INTERNATIONAL

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

(2016) Carolina Bonilla et al.   BMC Medicine

Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics

(2016) Marco Moschini et al.   BMC Medicine

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

(2016) Edward J Saunders et al.   BRITISH JOURNAL OF CANCER

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee

(2016) Emma L Turner et al.   BRITISH JOURNAL OF CANCER

Genetic predisposition to prostate cancer

(2016) S. Benafif et al.   BRITISH MEDICAL BULLETIN

Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?

(2016) Sean Harrison et al.   CANCER CAUSES & CONTROL

Radiotherapy for Prostate Cancer: is it ‘what you do’ or ‘the way that you do it’? A UK Perspective on Technique and Quality Assurance

(2016) M.D. Mason et al.   CLINICAL ONCOLOGY

Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study

(2016) Clarisse Kerleau et al.   EUROPEAN JOURNAL OF CANCER

Circulating Folate and Vitamin B 12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls

(2016) Alison J. Price et al.   EUROPEAN UROLOGY

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

(2016) Leonard P. Bokhorst et al.   EUROPEAN UROLOGY

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

(2016) Young Seok Ju et al.   GENOME RESEARCH

UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care

(2016) Damian Griffin et al.   HEALTH TECHNOLOGY ASSESSMENT

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

(2016) Carolina Bonilla et al.   INTERNATIONAL JOURNAL OF CANCER

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis

(2016) Amy E. Taylor et al.   INTERNATIONAL JOURNAL OF CANCER

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study

(2016) Clair Brunner et al.   INTERNATIONAL JOURNAL OF CANCER

Prostate-specific antigen testing rates and referral patterns from general practice data in England

(2016) S. Moss et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A new simple six-step model to promote recruitment to RCTs was developed and successfully implemented

(2016) Alba Realpe et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

PALB2,CHEK2andATMrare variants and cancer risk: data from COGS

(2016) Melissa C Southey et al.   JOURNAL OF MEDICAL GENETICS

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

(2016) Paula Mulvenna et al.   LANCET

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

(2016) John W Yaxley et al.   LANCET

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

(2016) Nicholas D James et al.   LANCET

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

(2016) Jenny L. Donovan et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

(2016) Freddie C. Hamdy et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer

(2016) Elena Castro et al.   ONCOLOGIST

Active surveillance for favorable-risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review

(2016) Eimear Ruane-McAteer et al.   PSYCHO-ONCOLOGY

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes

(2016) Andrew J Simpkin et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI)

(2016) Jenny L. Donovan et al.   Trials

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial

(2016) Eleanor I. Walsh et al.   Trials

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

(2016) Alexander Gusev et al.   Nature Communications

A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population

(2016) Jacek Marzec et al.   Oncotarget

Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses

(2016) Nikhil K. Khankari et al.   PLOS MEDICINE

Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians’ Practices across Six Randomised Controlled Trials

(2016) Leila Rooshenas et al.   PLOS MEDICINE

Blood lipids and prostate cancer: a Mendelian randomization analysis

(2016) Caroline J. Bull et al.   Cancer Medicine

Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies

(2015) Timothy J Key et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

(2015) Z. Kote-Jarai et al.   ANNALS OF ONCOLOGY

Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance

(2015) Patricia A. Parker et al.   BJU INTERNATIONAL

Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial

(2015) Julia Wade et al.   BMC HEALTH SERVICES RESEARCH

Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

(2015) Naomi J Williams et al.   BMC Medical Research Methodology

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

(2015) A. Amin Al Olama et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genome-Wide Association Study of Prostate Cancer-Specific Survival

(2015) R. Szulkin et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Wellbeing during Active Surveillance for localised prostate cancer: A systematic review of psychological morbidity and quality of life

(2015) Gregory Carter et al.   CANCER TREATMENT REVIEWS

The Molecular Taxonomy of Primary Prostate Cancer

(2015) Adam Abeshouse et al.   CELL

Should Gleason 6 be labeled as cancer?

(2015) Ibrahim Kulac et al.   CURRENT OPINION IN UROLOGY

Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer

(2015) Andrew J. Simpkin et al.   EUROPEAN UROLOGY

Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer

(2015) Neil E. Martin et al.   EUROPEAN UROLOGY

How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review

(2015) Lara Bellardita et al.   EUROPEAN UROLOGY

Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial

(2015) Rebecka Arnsrud Godtman et al.   EUROPEAN UROLOGY

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis

(2015) Nora Pashayan et al.   GENETICS IN MEDICINE

Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation

(2015) Craig R Ramsay et al.   HEALTH TECHNOLOGY ASSESSMENT

Gleason drift in the NIHR ProtecT study

(2015) Jon Oxley et al.   HISTOPATHOLOGY

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

(2015) Ali Amin Al Olama et al.   HUMAN MOLECULAR GENETICS

Physical activity, alcohol consumption, BMI and smoking status before and after prostate cancer diagnosis in the ProtecT trial: Opportunities for lifestyle modification

(2015) Lucy E. Hackshaw-McGeagh et al.   INTERNATIONAL JOURNAL OF CANCER

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

(2015) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

(2015) Richard J. Bryant et al.   JNCI-Journal of the National Cancer Institute

The evolutionary history of lethal metastatic prostate cancer

(2015) Gunes Gundem et al.   NATURE

Prediction of individual genetic risk to prostate cancer using a polygenic score

(2015) Robert Szulkin et al.   PROSTATE

Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer

(2015) L-M Wong et al.   PROSTATE CANCER AND PROSTATIC DISEASES

A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - quanti-qualitative appointment timing

(2015) Sangeetha Paramasivan et al.   Trials

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

(2015) S. Stegeman et al.   Cancer Discovery

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial

(2015) Julia Wade et al.   BMJ Open

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

(2015) Richard J. Bryant et al.   JNCI-Journal of the National Cancer Institute

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

(2015) H. Ross-Adams et al.   EBioMedicine

Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort

(2014) Ghassan A. Barayan et al.   BJU INTERNATIONAL

The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals

(2014) Kerry NL Avery et al.   BMC Family Practice

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

(2014) E L Turner et al.   BRITISH JOURNAL OF CANCER

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

(2014) G L Shaw et al.   BRITISH JOURNAL OF CANCER

American Cancer Society prostate cancer survivorship care guidelines

(2014) Ted A. Skolarus et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study

(2014) Rebecca Gilbert et al.   CANCER CAUSES & CONTROL

Adherence to Dietary and Lifestyle Recommendations and Prostate Cancer Risk in the Prostate Testing for Cancer and Treatment (ProtecT) Trial

(2014) V. Er et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genetic Variation in Prostate-Specific Antigen-Detected Prostate Cancer and the Effect of Control Selection on Genetic Association Studies

(2014) D. W. Knipe et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial

(2014) A Hay et al.   HEALTH TECHNOLOGY ASSESSMENT

Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada

(2014) Reka Pataky et al.   INTERNATIONAL JOURNAL OF CANCER

Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer

(2014) John N. Primrose et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials

(2014) Ronald C. Chen et al.   JNCI-Journal of the National Cancer Institute

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

(2014) J Athene Lane et al.   LANCET ONCOLOGY

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

(2014) Ali Amin Al Olama et al.   NATURE GENETICS

Polymorphisms of an Innate Immune Gene, Toll-Like Receptor 4, and Aggressive Prostate Cancer Risk: A Systematic Review and Meta-Analysis

(2014) Pei-Hsuan Weng et al.   PLoS One

‘What is this active surveillance thing?’ Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option

(2014) Clare O'Callaghan et al.   PSYCHO-ONCOLOGY

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

(2014) J. M. C. Tubio et al.   SCIENCE

Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials

(2014) Jenny L Donovan et al.   Trials

Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences

(2014) Nicola Mills et al.   Trials

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

(2014) Young Seok Ju et al.   eLife

Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer

(2013) Timothy J. Wilt   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer

(2013) Richard Johnston et al.   ANZ JOURNAL OF SURGERY

An Assessment of the Shared Allelic Architecture between Type II Diabetes and Prostate Cancer

(2013) O. H. Y. Yu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Using Genetic Proxies for Lifecourse Sun Exposure to Assess the Causal Relationship of Sun Exposure with Circulating Vitamin D and Prostate Cancer Risk

(2013) C. Bonilla et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer

(2013) D. W. Hamilton et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial

(2013) Anna Bill-Axelson et al.   EUROPEAN UROLOGY

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk

(2013) Karen A. Pooley et al.   HUMAN MOLECULAR GENETICS

Reporting of Patient-Reported Outcomes in Randomized Trials

(2013) Melanie Calvert et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Tracking the clonal origin of lethal prostate cancer

(2013) Michael C. Haffner et al.   JOURNAL OF CLINICAL INVESTIGATION

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

(2013) Rosalind A Eeles et al.   NATURE GENETICS

Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer

(2013) Matthew J. Resnick et al.   NEW ENGLAND JOURNAL OF MEDICINE

‘It's not like you just had a heart attack’: decision-making about active surveillance by men with localized prostate cancer

(2013) Robert J. Volk et al.   PSYCHO-ONCOLOGY

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid

(2013) Roger von Moos et al.   SUPPORTIVE CARE IN CANCER

Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models

(2012) Viacheslav Iremashvili et al.   BJU INTERNATIONAL

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis

(2012) Gisela Orozco et al.   BJU INTERNATIONAL

A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom

(2012) Nicholas J. Young et al.   CANCER CAUSES & CONTROL

Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the Prostate testing for cancer and Treatment study

(2012) Rebecca Gilbert et al.   CANCER CAUSES & CONTROL

Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study

(2012) Mari-Anne Rowlands et al.   CANCER CAUSES & CONTROL

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study

(2012) Anya Burton et al.   CANCER CAUSES & CONTROL

Associations of Lifestyle Factors and Anthropometric Measures with Repeat PSA Levels During Active Surveillance/Monitoring

(2012) A. J. Burton et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Evaluating Genetic Risk for Prostate Cancer among Japanese and Latinos

(2012) I. Cheng et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

(2012) A. Amin Al Olama et al.   HUMAN MOLECULAR GENETICS

The handling and sampling of radical prostatectomy specimens for reporting and research: the Oxford approach

(2012) Pelvender Singh Gill et al.   JOURNAL OF CLINICAL PATHOLOGY

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

(2012) Hashim U Ahmed et al.   LANCET ONCOLOGY

The effect of urinary incontinence on health utility and health-related quality of life in men following prostate surgery

(2012) Brian S. Buckley et al.   NEUROUROLOGY AND URODYNAMICS

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality-of-Life Effects of Prostate-Specific Antigen Screening

(2012) Eveline A.M. Heijnsdijk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Method for sampling tissue for research which preserves pathological data in radical prostatectomy

(2012) Anne Y. Warren et al.   PROSTATE

Incorporating prognostic factors into causal estimators: A comparison of methods for randomised controlled trials with a time-to-event outcome

(2012) Lisa V. Hampson et al.   STATISTICS IN MEDICINE

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK

(2011) Liz Down et al.   BJU INTERNATIONAL

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities

(2011) Naomi Williams et al.   BJU INTERNATIONAL

GENERAL APPLICATION OF THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) GUIDANCE FOR ACTIVE SURVEILLANCE FOR MEN WITH PROSTATE CANCER IS NOT APPROPRIATE IN UNSCREENED POPULATIONS

(2011) Masood A. Khan   BJU INTERNATIONAL

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

(2011) P Dimitropoulou et al.   BRITISH JOURNAL OF CANCER

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

(2011) N Pashayan et al.   BRITISH JOURNAL OF CANCER

Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer

(2011) Mari-Anne Rowlands et al.   CANCER CAUSES & CONTROL

Circulating Insulin-Like Growth Factors and IGF-Binding Proteins in PSA-Detected Prostate Cancer: The Large Case-Control Study ProtecT

(2011) M.-A. Rowlands et al.   CANCER RESEARCH

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

(2011) Z. Kote-Jarai et al.   HUMAN GENETICS

Genome-wide association study identifies new prostate cancer susceptibility loci

(2011) Fredrick R. Schumacher et al.   HUMAN MOLECULAR GENETICS

Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade

(2011) Rebecca Gilbert et al.   INTERNATIONAL JOURNAL OF CANCER

A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance

(2011) J. Athene Lane et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Exploring treatment preferences facilitated recruitment to randomized controlled trials

(2011) Nicola Mills et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Long-term quality of life in prostate cancer

(2011) Freddie C Hamdy   LANCET ONCOLOGY

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial

(2011) Eva Johansson et al.   LANCET ONCOLOGY

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

(2011) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)

(2011) Sangeetha Paramasivan et al.   Trials

The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review

(2010) O. Husson et al.   ANNALS OF ONCOLOGY

The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study

(2010) Mari-Anne Rowlands et al.   CANCER CAUSES & CONTROL

Associations of Folate, Vitamin B12, Homocysteine, and Folate-Pathway Polymorphisms with Prostate-Specific Antigen Velocity in Men with Localized Prostate Cancer

(2010) S. M. Collin et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis

(2010) S. M. Collin et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

(2010) A. J. Vickers et al.   CLINICAL CANCER RESEARCH

Prostate cancer incidence and mortality trends in 37 European countries: An overview

(2010) F. Bray et al.   EUROPEAN JOURNAL OF CANCER

Association of diabetes mellitus with prostate cancer: Nested case-control study (Prostate testing for cancer and Treatment study)

(2010) Emma L. Turner et al.   INTERNATIONAL JOURNAL OF CANCER

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: Findings from a large, population-based, case-control study (the ProtecT study)

(2010) Ali S. Murad et al.   INTERNATIONAL JOURNAL OF CANCER

Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies

(2010) Katherine S. Elliott et al.   PLoS One

The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine

(2010) Hayley C. Whitaker et al.   PLoS One

Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels

(2010) J. Gudmundsson et al.   Science Translational Medicine

Mutation analysis of the MSMB gene in familial prostate cancer

(2009) Z Kote-Jarai et al.   BRITISH JOURNAL OF CANCER

Anxiety and distress during active surveillance for early prostate cancer

(2009) Roderick C. N. van den Bergh et al.   CANCER

Genetic Variants in the Vitamin D Receptor Are Associated with Advanced Prostate Cancer at Diagnosis: Findings from the Prostate Testing for Cancer and Treatment Study and a Systematic Review

(2009) L. Chen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: A case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study

(2009) Simon M. Collin et al.   EUROPEAN JOURNAL OF CANCER

Men's experiences of radical prostatectomy as treatment for prostate cancer

(2009) Ella Walsh et al.   European Journal of Oncology Nursing

Development of a New Method for Monitoring Prostate-Specific Antigen Changes in Men with Localised Prostate Cancer: A Comparison of Observational Cohorts

(2009) Kate Tilling et al.   EUROPEAN UROLOGY

Life course sun exposure and risk of prostate cancer: Population-based nested case-control study and meta-analysis

(2009) Rebecca Gilbert et al.   INTERNATIONAL JOURNAL OF CANCER

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

PTGS2–899G>C and prostate cancer risk: a population-based nested case–control study (ProtecT) and a systematic review with meta-analysis

(2009) A Murad et al.   PROSTATE CANCER AND PROSTATIC DISEASES

It's not just what you say, it's also how you say it: Opening the ‘black box’ of informed consent appointments in randomised controlled trials

(2009) Julia Wade et al.   SOCIAL SCIENCE & MEDICINE

Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis

(2008) L. Zuccolo et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Qualitative research to improve RCT recruitment: Issues arising in establishing research collaborations

(2008) Isabel de Salis et al.   Contemporary Clinical Trials

Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness

(2008) Louise Howard et al.   Contemporary Clinical Trials

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial

(2008) Jenny L. Donovan et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial

(2008) A. Bill-Axelson et al.   JNCI-Journal of the National Cancer Institute

Optimal Parameters for the Destruction of Prostate Cancer Using Irreversible Electroporation

(2008) Jonathan Rubinsky et al.   JOURNAL OF UROLOGY

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

(2008) Martin G. Sanda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate biopsy in Switzerland: A representative survey on how Swiss urologists do it

(2008) Thomas Leippold et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

Active surveillance for prostate cancer: trials and tribulations

(2008) Laurence Klotz   WORLD JOURNAL OF UROLOGY

Decision-Making about PSA Testing and Prostate Biopsies: A Qualitative Study Embedded in a Primary Care Randomised Trial

(2007) Kerry N.L. Avery et al.   EUROPEAN UROLOGY

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group

(2007) C Metcalfe et al.   JOURNAL OF MEDICAL ETHICS